Tender Details

Country: Canada
Summary: Novartis Pharmaceuticals Canada Inc. - Lapatinib (Tykerb®)
CAT Ref No: 68651222
Deadline: 15 Jul 2022
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 00003141763
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Novartis Pharmaceuticals Canada Inc. - lapatinib (Tykerb®)
Solicitation Type : NOI - Notice of Intent (Informal)
Solicitation Number : 3464
Location : British Columbia
Purchase Type : Not Stated

Description : Notice is hereby given PROVINCIAL HEALTH SERVICES AUTHORITY (“PHSA”), acting on its own behalf, and as agent for FRASER HEALTH AUTHORITY, INTERIOR HEALTH AUTHORITY, NORTHERN HEALTH AUTHORITY, VANCOUVER COASTAL HEALTH AUTHORITY AND VANCOUVER ISLAND HEALTH AUTHORITY (“Health Authorities”), intends to directly award a Contract to the following supplier to provide lapatinib (Tykerb®). The initial term will be for a three (3) year terms, with a two (2) year option to extend. The contract has an estimated value of $104.0K CAD over the five (5) year term. Novartis Pharmaceuticals Canada Inc. 385 Boul. Bouchard Dorval, QC, Canada H9S 1A9 In accordance with applicable trade agreements, PHSA, as agent for the Health Authority(s) has chosen not to proceed with a competitive process because the goods can be supplied only by the selected supplier and no alternative or substitute exists for the following reason: (a) the protection of patents, copyrights or other exclusive rights Vendors who wish to challenge this decision should submit a detailed written objection for the attention of David Peters, Buyer, Clinical Sourcing Pharmacy, by email before 2:00pm Pacific Time, July 15, 2022 PHSA will review any and all issues received by this date and provide due con...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Novartis Pharmaceuticals Canada Inc. - Lapatinib (Tykerb®) - Canada Tender

The PROVINCIAL HEALTH SERVICES AUTHORITY BC, a Government sector organization in Canada, has announced a new tender for Novartis Pharmaceuticals Canada Inc. - Lapatinib (Tykerb®). This tender is published on CanadaTenders under CAT Ref No: 68651222 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-07-15.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.